Skip to content



  1. Content type: Research


Most accessed articles RSS

View all articles

Editors' profiles

Chi Van Dang, Editor Emeritus

Chi Dang is a professor, physician-researcher, renowned cancer biologist and hematologist-oncologist, who serves as director of the Abramson Cancer Center at the University of Pennsylvania.

"After several decades of profound advances in our understanding of the genetics and molecular biology of cancer, it has become self-evident that metabolism and bioenergetics are regulated by cancer genes and are intimately linked to the growth and survival of cancer cells. The obesity pandemic connected to increased cancer risk further underscore the importance of a richer understanding of cancer and organismal metabolism. In this regard, Cancer & Metabolism is launched uniquely to fulfill the needs of a burgeoning field which is at the crossroads of many scientific disciplines."

Dr. Michael Pollak, co-Editor-in-Chief

Dr. Pollak is an internationally recognized expert in cancer endocrinology at the Lady Davis Institute for Medical Research of McGill University and a clinical oncologist at the Jewish General Hospital, Quebec, Canada.

"Cancer & Metabolism will provide a forum for rapid dissemination of research findings concerning metabolic factors that influence cancer risk and cancer pathophysiology, and cancer treatment. The scope of the Journal will allow for an interdisciplinary readership including cancer biologists, endocrinologists, oncologists, clinical trialists and population scientists."

New Content ItemDr. Matthew G. Vander Heiden, co-Editor-in-Chief

Dr. Vander Heiden is Associate Director at the Koch Institute for Integrative Cancer Research at MIT. His other roles include Instructor in Medicine at Dana-Farber Cancer Institute and Harvard Medical School. Extensively published in over 140 peer reviewed articles and book chapters, his research interests focus on the metabolic processes of cancer cells, including how glucose metabolism affects tumor growth and how these studies may lead to new developments in targeted cancer therapy. A renowned innovative researcher in his field, Dr. Vander Heiden received the 2017 Philip A. Sharp Innovation in Collaboration Award from Stand Up to Cancer (SU2C), complementing his past awards in molecular oncology.


Cancer & Metabolism publishes selected collections of research articles, conference proceedings, reviews and reports as supplements. While we build our new sites all supplements will be available here.


Michael Pollak, McGill University, Canada

Matthew Vander Heiden, Massachusetts Institute of Technology, USA

Senior Editors

Kevin Brindle, University of Cambridge, UK
Navdeep Chandel, Northwestern University, USA
Ralph DeBerardinis, University of Texas Southwestern Medical Center, USA
Eyal Gottlieb, Beatson Institute for Cancer Research, UK

Editor Emeritus

Chi Van Dang, University of Pennsylvania, USA

Aims and scope

Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer including Molecular biology and genetics of cancer.

Read more

Efficient peer review

We recognize that scientifically sound, high-quality manuscripts often receive negative decisions from high-impact journals on the basis of perceived general interest levels or the absence of extensive mechanisms supporting research hypotheses. As a niche journal, Cancer & Metabolism will consider rapid publication of such manuscripts if they are submitted together with the original peer reviewer reports, letter of rejection, and a brief rebuttal.

Featured article: Mathematical models of cancer metabolism

This review highlights the recent advances on the mathematical models of cancer metabolism. 

Article collections

Cross journal article collection


Guest edited by Navdeep Chandel (on behalf of Cancer & Metabolism), Martin Brand, Andrew Murray, Jodi Nunnari and Peter Walter, this cross journal collection focuses on all aspects of mitochondrial function in cancer and metabolism.

Read more


Annual Journal Metrics

  • Speed
    63 days to first decision for reviewed manuscripts only
    55 days to first decision for all manuscripts
    123 days from submission to acceptance
    27 days from acceptance to publication

    145 Altmetric Mentions